IOB - Delayed Quote CHF
Idorsia Ltd (0RQE.IL)
1.4900
+0.2000
+(15.50%)
At close: May 2 at 4:30:22 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-470,222
-629,296
-859,108
-589,895
-364,667
Investing Cash Flow
358,042
632,614
743,901
-53,257
-607,131
Financing Cash Flow
-80
-197
162,310
604,146
850,076
End Cash Position
93,019
145,052
145,998
101,352
140,810
Capital Expenditure
-18,160
-9,398
-27,058
-30,931
-9,286
Issuance of Capital Stock
--
--
360
10,000
850,077
Issuance of Debt
--
60,000
161,950
594,564
--
Repayment of Debt
--
-60,000
--
--
--
Repurchase of Capital Stock
-80
-197
--
-418
--
Free Cash Flow
-488,382
-638,694
-886,166
-620,826
-373,953
12/31/2020 - 6/16/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RV7.BE Halozyme Therapeutics Inc
52.86
-0.34%
NVCT Nuvectis Pharma, Inc.
9.25
-3.85%
OSTX OS Therapies Incorporated
2.0400
+5.70%
GUTS Fractyl Health, Inc.
1.5800
+24.41%
TLSA Tiziana Life Sciences Ltd
1.2800
-0.78%
LCTX Lineage Cell Therapeutics, Inc.
0.4907
-2.64%
ABEO Abeona Therapeutics Inc.
6.56
-4.51%
TNYA Tenaya Therapeutics, Inc.
0.5200
+1.96%
SLS SELLAS Life Sciences Group, Inc.
1.7400
+7.41%
BLUE bluebird bio, Inc.
3.9500
-2.47%